Efficacy and safety of tabalumab in patients with relapsing-remitting multiple sclerosis: A randomized, double-blind, placebo-controlled study

Authors
Category Primary study
JournalNeurology
Year 2018
This article has no abstract
Epistemonikos ID: 716040c7712189f4a1fb88e129fb590f82b94a90
First added on: Feb 09, 2025